A Phase II Study of KUC-7483 in Patients With Overactive Bladder

NCT00742833 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder (OAB)

Interventions

DRUG: KUC-7483
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.